×

IMPORTANT MESSAGE REGARDING COVID-19

The ESCP realizes that we are in extraordinary times with COVID-19 affecting our private and working life. Many people, including clinical pharmacists, are working to control the virus and its consequences.

At this moment, we can’t foresee how COVID-19 might affect the activities of the ESCP, including our autumn symposium from the 28th – 30th of October in Lisbon. Of course, we hope that this symposium will be held as scheduled, however, the General Committee of the ESCP and the symposium organizers take into account that the symposium may need to be rescheduled.

Time will teach us, how COVID-19 will influence our lives after the summer. We expect to have some more information by the end of April 2020 and based on this information the ESCP will decide how to proceed.

Therefore, the General Committee has decided together with the organizers of the ESCP Lisbon symposium to postpone the opening of the participant registration and the opening of the Abstract submission (=abstracts for Poster Presentations and Oral Communications)

The GC will send you an update by the end of April.

 

Stay healthy!

Dr BJF (Bart) van den Bemt, president of the ESCP

Welcome to the ESCP Symposium Lisbon!

Dear Colleagues,

“Clinical pharmacy, working collaboratively in mental health care” was the theme chosen for this year’s conference, following the launch from the World Health Organization establishing a comprehensive mental health plan for 2013-2020! This plan Urges member states to implement the proposed actions adapted to their national and specific circumstances. The WHO also invites international, regional and national partners to take note of this comprehensive mental health plan. Portugal is the European country with the second highest prevalence of psychiatric problems, only surpassed by Northern Ireland. In fact, the burden of illness caused by mental health and behavioural disturbances in Portugal is 11.8%, higher than estimated for oncology. All these facts make the choice of theme very relevant from an international perspective but also adapted to the national context. Allied to the celebration of the Mental Health day on the 10th October, instituted by the World Federation of Mental Health, the ESCP will want to engage in providing up-to-date science and education on clinical pharmacy by holding its annual conference in October, dedicated to Mental Health.

The 49th ESCP Symposium will provide attendees with the opportunity to be involved in the discussion around mental health issues in the context of clinical pharmacy. Features of interest include updates on dementia, depression, anxiety and psychosis treatment. Of highlight are also new concepts of “mental health first aid” and “precision mental health”. Aligning the conference with patient-centred pharmaceutical care, focus will be put on patient involvement in shared decision making. During the symposium, every day there will be a lecture focusing on pharmacotherapy updates, highlighting evidence-based therapy and controversies in the treatment of dementia, depression and anxiety. Other topics focused in plenary lectures will include: number needed to treat and number needed to harm in mental health; treatment of dementia-related pain; deprescribing of benzodiazepines; treatment of mental health using digital technology to reach the youth; comparing the benefits of pharmacotherapy and psychotherapy, to name a few. There will also be masterclasses focusing on general research and educational themes, namely “Bring your paper to get it published” and “Teaching by the bedside” or “Multivariate statistical analsyis”. We welcome workshop proposals especially on related topics, such as: short interventions for substances of abuse; monitoring of psychotropic drug use in older patients; using analytical methods to understand risk factors for mental disorders; impacts of gaming in mental health; but also general themes, including: developing a research protocol; how to get an abstract accepted, to name a few.

The ESCP Symposium is an excellent opportunity to present your scientific work (as oral communication or as a poster) or to meet your colleagues. Looking forward to meeting you in Lisboa (Portugal) from 28 – 30 October 2020!

Filipa Alves da Costa
Symposium President

Organising Committee

  • Filipa Alves da Costa (Portugal) - Chair

  • Stephane Steurbaut (Belgium)

  • Marie-Caroline Husson (France)

  • Edwin van Aalten (The Netherlands)

  • Daniela Fiavolá (Czech Republic)

Scientific Committee

  • Mara Guerreiro (Portugal) - Chair

  • Hege Blix (Norway)

  • Martin Henman (Ireland)

  • Francisca Desplenter (Belgium)

  • Yolande Hanssens (Qatar)

Local Host Committee

  • Catarina Luz Oliveira
  • Sílvia Rodrigues
  • Helena Farinha
  • Ema Paulino
  • Sofia Crisóstomo

Supported by

×

Important Dates & Deadlines

Workshop submission call 15 February 2020
Workshop proposal deadline postponed
Registration Opening postponed
Abstract Submission Opening postponed
Abstract Submission Deadline 1 June 2020
Early Bird Registration Deadline 15 Sept 2020
Regular Registration Deadline 26 October 2020
Conference 28 –30 October 2020

User login

About ESCP

The European Society of Clinical Pharmacy (ESCP) is an organization that promotes, supports, implements and advances education, practice and research in clinical pharmacy in order to optimize outcomes for patients and society.

Get in touch

ESCP International Office
Theda Mansholtstraat 5B
2331JE Leiden
Netherlands

+31 715 766 157
Tu, We, Fr from 9 am - 4 pm